Primary Disease Clinical Trial
— SDLOfficial title:
Study of the Second Hospital of Qinhuangdao
Verified date | October 2010 |
Source | The Second Hospital of Qinhuangdao |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Ethics Committee |
Study type | Observational |
Traumatic sesamoid displacement of the first metacarpophalangeal joint can affect thumb function.
Status | Completed |
Enrollment | 1 |
Est. completion date | April 2010 |
Est. primary completion date | January 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Traumatic sesamoid displacement Exclusion Criteria: - Pathologic sesamoid disorder |
Observational Model: Case-Only, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
The Second Hospital of Qinhuangdao |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03702361 -
Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease
|
Phase 4 | |
Completed |
NCT00405210 -
Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer
|
Phase 1 | |
Completed |
NCT01325194 -
CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
|
Phase 2 | |
Completed |
NCT00803244 -
Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis (With or Without Asthma)
|
Phase 3 | |
Completed |
NCT00552461 -
Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
|
Phase 2 | |
Terminated |
NCT01868243 -
Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
|
Phase 2/Phase 3 | |
Completed |
NCT01323894 -
Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling
|
N/A |